Cardio‐Kidney‐Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease

20260 citationsJournal Articlehybrid Open Access

Authors

Enrico Repetto · Rolls-Royce (United States)

Christopher Perkins · Rolls-Royce (United States)

Ambarish Pandey · The University of Texas Southwestern Medical Center

Peter Rossing · University of Copenhagen

Abstract

CKM therapy was frequently used in patients with Type 1 diabetes and CKD, associated with UACR reduction and safe. These clinically relevant data warrant confirmation in randomised clinical trials.

Topics & Keywords

Chronic Kidney Disease and Diabetes Dialysis and Renal Disease Management Diabetes Treatment and Management

Publication Details

Published in: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.70640

Field-Weighted Citation Impact: 0.00

Command Palette

Cardio‐Kidney‐Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease

Authors

Abstract

Topics & Keywords

Publication Details